Sustained virological response after treatment in patients with chronic hepatitis C infection - A five year follow up

Bangladesh Medical Research Council Bulletin

Volumn 39, Issue 1, 2013, Pages 11-13

  Rahman, M Z ^a   Ahmed, D S ^a   Masud, H ^a   Parveen, S ^a   Rahman, M A ^a   Chowdhury, M S ^a   Barua, R ^a   Ishaque, S M ^a  

^a BANGABANDHU SHEIKH MUJIB MEDICAL UNIVERSITY   (Bangladesh)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; HEPATITIS B SURFACE ANTIGEN; PEGINTERFERON ALPHA2A; RIBAVIRIN; VIRUS RNA;

ADULT; ANTIVIRAL THERAPY; ARTICLE; ECHOGRAPHY; FEMALE; FOLLOW UP; HEMATOLOGY; HEPATITIS C; HUMAN; LIVER CIRRHOSIS; LIVER FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; PHYSICAL EXAMINATION; PROTHROMBIN TIME; RECURRENCE RISK; SUSTAINED VIROLOGICAL RESPONSE; TREATMENT RESPONSE;

EID: 84880903911     PISSN: 03779238     EISSN: None     Source Type: Journal    
DOI: 10.3329/bmrcb.v39i1.15791     Document Type: Article

References (19)

1. Watanabe H, Saito T, Shinzawa H, et al. Spontaneous elimination of serum hepatitis C virus (HCV) RNA in chronic HCV carriers: a population-based cohort study. J Med Virol. 2003; 71: 56-61.
2. Scott JD, McMahon BJ, Bruden D, et al. High rate of spontaneous negativity for hepatitis C virus RNA after establishment of chronic infection in Alaska Natives. Clin Infect Dis.2006; 42: 945-52.
3. Santantonio T, Piccinino F, Andreone P, et al. Sustained virological response to interferon-alpha is associated with improved outcome in HCV-related cirrhosis: a retrospective study Hepatology. 2007; 45: 597-87.
4. Maylin S, Martinot-Peignoux M, Moucari R, et al. Eradication of hepatitis C virus in patients successfully treated for chronic hepatitis C. Gastroenterology. 2008; 135: 821-9.
5. Sood A, Midha V, Hissar S, et al. Comparison of lowdose pegylated interferon versus standard high-dose pegylated interferon in combination with ribavirin in patients with chronic hepatitis C with genotype 3: an India experience . J Gastroenterol Hepatol. 2008; 23: 203-7.
6. Gupta R, Ramakrishna CH, Lakhtakia S, Tandan M, Banerjee R, Reddy DN. Efficacy of low dose peginterferon alpha-2b with ribavirin on chronic hepatitis c. World J Gastroenterol. 2006; 12: 5554-6.
7. Martiont M, Marcellin P, Boyer N, et al. Influence of hepatitis G virus infection on the severity of liver disease and response to interferon-alpha in patients with chronic hepatitis C. Ann Intern Med. 1997; 126: 874-81.
8. Lau Dt, Kleiner DE, Ghany MG, Park Y, Schmid P, Hoofnagle JH. 10 year follow up after interferon-alpha therapy for chronic hepaptitis C. Hepatology. 1998; 28: 1121-7.
9. Reichard O, Glaumann H, Fryden A, Norkrans G, Wejstal R. Weiland O. long-term follow up of chronic hepatitis C patients with sustained virological reponse to alpha-interferon. J Hepatol 1999;30:783-7.
10. McHutchison JG, Poynard T, Esteban-Mur R, et al. Hepatic HCV RNA before and after treatment with interferon alone or combined with ribavirin. Hepatology. 2002; 35: 688-93.
11. Ghany MG, Strader DB, Thomas DL, Seeff LB, American association for the study of Liver Disease. Diagnosis, management and treatment of hepatitis C: an update, Hepatology. 2009; 49: 1335-74.
12. Veldt BJ, Saracco G, Boyer N, et al. Long term clinical outcome of chronic hepatitis C patients with sustained virological response to interferon monotherapy. Gut. 2004; 53: 1504-8.
13. Camma C, giunta M, Pinzello G, Morabito A, Verderio P, Pagliaro L. Chronic hepatitis C and interferon alpha: conventional and cumulative meta-analyses of randomized controlled trials. Am J Gastroenterol. 1999; 94: 581-95.
14. Radkowski M, Gallegos-Orozco JF, Jablonska J, et al. Persistence of hepatitis C virus in patients successfully treated for chronic hepatitis C. Hepatology. 2005; 41: 106-14.
15. Swain M, Lai MY, Shiffman ML, et al. Durability of sustained virologucal response (SVR) after treatment with peginterferon alpha2A (40kD) (PEGASYS) alone or in combination with ribavirin (Copegus): results of an ongoing long-term follow upstudy. Hepatology. 2004; 40(suppll): 400A; AASLD2004.
16. Formann E, Steindl-Munda P, Hofer H, et al. Longterm follow up of chronic hepatitis C patients with sustained virological response to various forms of interferon-based anti-viral therapy. Aliment Pharmacol Ther. 2006; 23: 507-11.
17. Tsuda N, Yuki N, Mochizuki K, et al. Long-term clinical and virological outcomes of chronic hepatitis C after successful interferon therapy. J Med Virol. 2004; 74: 406-13.
18. George SL, Bacon BR, Brunt EM, Mihindukulasuriya KL, Hoffmann J, Di Bisceglie AM. Clinical virologic, histologic and biochemical outcomes after successful HCV therapy: a 5 year follow up of 150 patients. Hepatology. 2009; 49:729-38.
19. MZ Rahman, et al. Response with peginterferon alpha- 2A and Ribavirin in chronic Hepatitis C: Bangladesh J Medical 2008; 19: 13-18.